Status:
ACTIVE_NOT_RECRUITING
Ventricular Pacing Rate in Follow-up of Patients Treated With Definitive PM Implantation Post TAVI
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Aortic Stenosis
Conduction Defect, Cardiac
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to learn about the effective ventricular pacing rate in follow-up of patients who underwent a pacemaker (PM) implantation after transcatheter aortic valve impla...
Detailed Description
Aortic stenosis represents the most common valve defect in developed countries. Percutaneous transcatheter aortic valve implantation (TAVI) is now a first-line therapy for aortic stenosis. The develo...
Eligibility Criteria
Inclusion
- PM implantation following TAVI surgery, during the same hospitalization
- Signature of informed consent
- Over the age of 18.
Exclusion
- PM implantation prior to hospitalization for TAVI
- PM implantation during hospitalization different from the hospitalization for TAVI
- Pregnant or breastfeeding women
Key Trial Info
Start Date :
April 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 10 2026
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT06499428
Start Date
April 10 2024
End Date
June 10 2026
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Ospedale GAleazzi-Sant'Ambrogio
Milan, Italy, 20132